Log in

NDC Nam Duoc JSC UPCOM · Vietnam

Nam Duoc JSC (NDC) news

Nam Duoc JSC is a public biotech or pharmaceutical company listed on UPCOM under the ticker NDC, recorded under Vietnam. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Nam Duoc JSC news

We have not published a story on Nam Duoc JSC yet. When there is news, it will appear here.

Questions about Nam Duoc JSC

What is the ticker symbol of Nam Duoc JSC?

Nam Duoc JSC trades under the ticker NDC on UPCOM.

Where is Nam Duoc JSC listed?

Nam Duoc JSC is listed on UPCOM.

Which country or territory is Nam Duoc JSC listed under?

Our directory records Nam Duoc JSC under Vietnam.

What does Nam Duoc JSC do?

Our directory classifies Nam Duoc JSC as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of Nam Duoc JSC?

The ISIN recorded for Nam Duoc JSC is VN000000NDC7.

Does aibio.space cover Nam Duoc JSC?

aibio.space lists Nam Duoc JSC among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Nam Duoc JSC?

Companies in our directory listed in the same country and business area as Nam Duoc JSC: OPC Pharmaceutical Joint Stock, F.I.T Group Joint Stock, Binh Dinh Pharmaceutical & Medical Equipment JSC, DakLak Pharmaceutical Medical Equipment JSC, Green Plus Joint Stock, Armephaco Joint Stock Co.

Investor discussion: Nam Duoc JSC

Members talk about Nam Duoc JSC (NDC). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Listing details

Nam Duoc JSC is a public biotech or pharmaceutical company listed on UPCOM under the ticker NDC, recorded under Vietnam. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Nam Duoc JSC
Ticker
NDC
Listing
UPCOM
Country or territory
Vietnam
Business scope
Pharmaceuticals: Major
ISIN
VN000000NDC7
Last quote in directory
2026-10-21
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.